Managed Access Programs for TQJ230, Pelacarsen

Sponsor
Novartis Pharmaceuticals
Study ID
NCT07000695
Status
Available

Conditions

  • Atherosclerotic Cardiovascular Disease, ASCVD

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this registration is to list Managed Access Programs (MAPs) related to TQJ230, pelacarsen

Key Dates

Status verified
May 2025

Central Contacts